143 related articles for article (PubMed ID: 18473712)
1. Co-administration of opioid agonists and antagonists in addiction and pain medicine.
Leri F
Expert Opin Pharmacother; 2008 Jun; 9(8):1387-96. PubMed ID: 18473712
[TBL] [Abstract][Full Text] [Related]
2. Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management.
Sadee W; Oberdick J; Wang Z
Molecules; 2020 Sep; 25(18):. PubMed ID: 32932935
[TBL] [Abstract][Full Text] [Related]
3. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
4. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.
Ko MC; Tuchman JE; Johnson MD; Wiesenauer K; Woods JH
Psychopharmacology (Berl); 2000 Feb; 148(2):180-5. PubMed ID: 10663433
[TBL] [Abstract][Full Text] [Related]
5. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
Holder RM; Rhee D
Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
[TBL] [Abstract][Full Text] [Related]
6. The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research.
Walsh SL; Babalonis S
Curr Top Behav Neurosci; 2017; 34():33-58. PubMed ID: 27356522
[TBL] [Abstract][Full Text] [Related]
7. Opioid antagonists, partial agonists, and agonists/antagonists: the role of office-based detoxification.
Helm S; Trescot AM; Colson J; Sehgal N; Silverman S
Pain Physician; 2008; 11(2):225-35. PubMed ID: 18354714
[TBL] [Abstract][Full Text] [Related]
8. Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.
Woolf CJ; Hashmi M
Curr Opin Investig Drugs; 2004 Jan; 5(1):61-6. PubMed ID: 14983975
[TBL] [Abstract][Full Text] [Related]
9. Combining opioids and non-opioids for pain management: Current status.
Li JX
Neuropharmacology; 2019 Nov; 158():107619. PubMed ID: 31029588
[TBL] [Abstract][Full Text] [Related]
10. The attractiveness of opposites: agonists and antagonists.
O'Brien T
J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):67-9. PubMed ID: 25643224
[TBL] [Abstract][Full Text] [Related]
11. Office-based opioid dependence treatment.
Colson J; Helm S; Silverman SM
Pain Physician; 2012 Jul; 15(3 Suppl):ES231-6. PubMed ID: 22786460
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine for opioid dependence.
Milne M; Crouch BI; Caravati EM
J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
[TBL] [Abstract][Full Text] [Related]
13. Opioid and adjuvant analgesics: compared and contrasted.
Khan MI; Walsh D; Brito-Dellan N
Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
[TBL] [Abstract][Full Text] [Related]
14. Benefits and Limits of Abuse-Deterrent Painkillers.
Hendrikson H; Hanson K
NCSL Legisbrief; 2016 Feb; 24(6):1-2. PubMed ID: 27032127
[TBL] [Abstract][Full Text] [Related]
15. A Clinical Study on Administration of Opioid Antagonists in Terminal Cancer Patients: 7 Patients Receiving Opioid Antagonists Following Opioids among 2443 Terminal Cancer Patients Receiving Opioids.
Uekuzu Y; Higashiguchi T; Futamura A; Ito A; Mori N; Murai M; Ohara H; Awa H; Chihara T
Biol Pharm Bull; 2017 Mar; 40(3):278-283. PubMed ID: 27980244
[TBL] [Abstract][Full Text] [Related]
16. Responsible prescribing of opioids for the management of chronic pain.
Nicholson B
Drugs; 2003; 63(1):17-32. PubMed ID: 12487620
[TBL] [Abstract][Full Text] [Related]
17. Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone.
Cruciani RA; Lussier D; Miller-Saultz D; Arbuck DM
J Pain Symptom Manage; 2003 Jun; 25(6):491-4. PubMed ID: 12782427
[No Abstract] [Full Text] [Related]
18. Improving opioid effectiveness: from ideas to evidence.
Kalso E
Eur J Pain; 2005 Apr; 9(2):131-5. PubMed ID: 15737801
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
Abul-Husn NS; Sutak M; Milne B; Jhamandas K
Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
[TBL] [Abstract][Full Text] [Related]
20. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
